http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012017448-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31c3812877d9d6605b10e94c37792c7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58873f061bd752352629dc78a479bbc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71d0c7d1a7ce6d335f2593d32ae8d518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a615b6db0acb71ee30f71f157888ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8bfd608990c37357d85146f05e42e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f8aaff1117f200db3a672b6d11cab6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d89b8ca95cc066837db1f89678672a1e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-72
filingDate 2011-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def797b21352fbbe2d1897b890dc6e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbd3a695843b18ad256fc05a3d582fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03107b15bb1b77ce6472455f50197af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a21742e78626bf9abf96241cf3c46e85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a10c3063e8167f2f35212fb30733fc6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ffbf58d87ff981e9d88d0c4bd46924
publicationDate 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012017448-A3
titleOfInvention Salts of lapatinib
abstract The present invention provides novel dioxalate salt of lapatinib, process for its preparation and pharmaceutical compositions comprising it. The present invention also provides novel monobesylate salt of lapatinib, process for its preparation and pharmaceutical compositions comprising it. The present invention further provides a process for the preparation of monohydrate form of lapatinib ditosylate. The present invention further provides a process for the preparation of anhydrous form of lapatinib ditosylate.
priorityDate 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003049291-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004218078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4804448-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9941095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453203007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492306

Total number of triples: 31.